Garheng Kong
CIK 1435183 · last filed 2026-06-05
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$57.38M
Companies
10
Total Filings
77
Lifetime Open-Market Net
-$21.82M
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
Filer Profile
Reported Address
712 COLLEGE AVENUEMENLO PARK, CA 94025
Related Filers
LABORATORY CORP OF AMERICA HOLDINGS — 26 joint filings, latest 2026-02-13
Sofinnova HealthQuest Partners, L.P. — 10 joint filings, latest 2020-05-19
HealthQuest Venture Management, L.L.C. — 9 joint filings, latest 2020-05-19
American Oncology Network, Inc. — 1 joint filings, latest 2023-11-09
JAMES HEALY — 1 joint filings, latest 2012-10-04
MICHAEL POWELL — 1 joint filings, latest 2012-10-04
Sofinnova Management VIII, L.L.C. — 1 joint filings, latest 2012-10-04
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses.
View filings on SEC EDGAR.
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| XERS | Director | 238,337 | $9.08 | $2.16M | $0 | 7 | 2026-06-05 |
| LH | Director | 13,739 | $308.49 | $4.24M | $0 | 24 | 2026-02-13 |
| Venus Concept Inc. (VERO) Delisted | Director | 41,186 | $0.31 | $12.8K | $2.00M | 8 | 2023-03-28 |
| ALIMERA SCIENCES INC (ALIM) Delisted | Director | — | $5.54 | — | $0 | 12 | 2023-01-06 |
| Strongbridge Biopharma plc (SBBP) Delisted | Director | 0 | $2.00 | $0 | $0 | 8 | 2021-10-06 |
| CSTL | 10%+ Owner | 1,433,577 | $35.56 | $50.98M | -$25.87M | 1 | 2020-05-14 |
| AVEDRO INC (AVDR) Delisted | Director | 0 | $24.25 | $0 | $2.00M | 3 | 2019-11-26 |
| Venus Concept Inc. (HAIR) Delisted | Director | 177,486 | — | — | $0 | 1 | 2019-11-07 |
| MELINTA THERAPEUTICS, INC. /NEW/ (MLNT) Delisted | Director | — | — | — | $0 | 1 | 2018-06-14 |
| MELINTA THERAPEUTICS, INC. /NEW/ (CEMP) Delisted | Director | 2,830 | — | — | $49.3K | 7 | 2017-01-05 |
Recent Filings · Page 4 of 8
77 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-06-22 | ALIMERA SCIENCES INC (ALIM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-06-18 | Venus Concept Inc. (VERO) Delisted | Conv (C) | +1,200,000 | $0 | EDGAR |
| 2020-05-18 | Strongbridge Biopharma plc (SBBP) Delisted | Tax (F) | −19,044 | -$54.5K | EDGAR |
| 2020-05-15 | Strongbridge Biopharma plc (SBBP) Delisted | Grant (A) | +40,000 | $0 | EDGAR |
| 2020-05-14 | CSTL | Sell (S) | −750,000 | -$25.87M | EDGAR |
| 2020-04-01 | Venus Concept Inc. (VERO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-03-20 | Venus Concept Inc. (VERO) Delisted | Buy (P) | — | $0 | EDGAR |
| 2020-02-14 | LH | Exer (M) | +1,227 | $0 | EDGAR |
| 2020-02-07 | LH | Grant (A) | — | $0 | EDGAR |
| 2019-11-26 | AVEDRO INC (AVDR) Delisted | Disp (D) | −1,437,096 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.